(Q35030833)

English

Systematic review: serotonergic modulators in the treatment of irritable bowel syndrome--influence on psychiatric and gastrointestinal symptoms

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1 reference

Europe PubMed Central

Systematic review: serotonergic modulators in the treatment of irritable bowel syndrome--influence on psychiatric and gastrointestinal symptoms (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

systematic review

1 reference

based on heuristic

inferred from title

author name string

T O C Kilkens

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

A Honig

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

N Rozendaal

3

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

M A Van Nieuwenhoven

4

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

R-J M Brummer

5

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

language of work or name

0 references

publication date

1 January 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

17

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

43-51

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Emerging disease model for functional gastrointestinal disorders

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

Serotoninergic neuroenteric modulators

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

Reduction of gastrointestinal symptoms following treatment for panic disorder.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

Comorbidity of gastrointestinal complaints, depression, and anxiety in the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

Prevalence of psychiatric disorders in patients with irritable bowel syndrome.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

Irritable bowel syndrome and psychiatric illness

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

Psychiatric illness and irritable bowel syndrome: a comparison with inflammatory bowel disease.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

Treatment of depression in Parkinson's disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

Alosetron improves quality of life in women with diarrhea-predominant irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

Irritable colon and depression

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

Therapeutic usefulness of amitriptyline in spastic colon syndrome.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

Personality traits predict treatment outcome with an antidepressant in patients with functional gastrointestinal disorder

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

Review article: roles played by 5-hydroxytryptamine in the physiology of the bowel

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

Diarrhea- and constipation-predominant IBS patients differ in postprandial autonomic and cortisol responses

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

Development of a Rating Scale for Primary Depressive Illness

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

Panic disorder and gastrointestinal symptoms: findings from the NIMH Epidemiologic Catchment Area project

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

The efficacy of amineptine in the treatment of depressive patients with irritable bowel syndrome

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

Predominant symptoms in irritable bowel syndrome correlate with specific autonomic nervous system abnormalities

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2003.01388.X

21 January 2018

Identifiers

10.1046/J.1365-2036.2003.01388.X

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

release_t25kjx3sjbc5fhatzt7o6harnu

1 reference

https://api.fatcat.wiki/v0/release/t25kjx3sjbc5fhatzt7o6harnu

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35030833&oldid=1967123865"